Tanespimycin
- Generic Name
- Tanespimycin
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C31H43N3O8
- CAS Number
- 75747-14-7
- Unique Ingredient Identifier
- 4GY0AVT3L4
- Background
Tanespimycin, manufactured by Conforma Therapeutics is under development as a small molecule inhibitor of heat shock protein 90 (HSP90). It is developed for the treatment of several types of cancer, solid tumors or chronic myelogenous leukemia.
- Indication
Investigated for use/treatment in leukemia (myeloid) and solid tumors.
- Associated Conditions
- -
- Associated Therapies
- -
No trials found
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath